OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and in vitro studies of the correlation between MGMT and the effect of streptozocin in pancreatic NET
Susumu Hijioka, Keiichiro Sakuma, Masahiro Aoki, et al.
Cancer Chemotherapy and Pharmacology (2018) Vol. 83, Iss. 1, pp. 43-52
Closed Access | Times Cited: 19
Susumu Hijioka, Keiichiro Sakuma, Masahiro Aoki, et al.
Cancer Chemotherapy and Pharmacology (2018) Vol. 83, Iss. 1, pp. 43-52
Closed Access | Times Cited: 19
Showing 19 citing articles:
The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review
Giulia Arrivi, Nicola Fazio, Salvatore Tafuto, et al.
Cancer Treatment Reviews (2025), pp. 102899-102899
Open Access | Times Cited: 1
Giulia Arrivi, Nicola Fazio, Salvatore Tafuto, et al.
Cancer Treatment Reviews (2025), pp. 102899-102899
Open Access | Times Cited: 1
Critical appraisal of MGMT in digestive NET treated with alkylating agents
Louis de Mestier, Anne Couvelard, Anela Blažević, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 10, pp. R391-R405
Open Access | Times Cited: 20
Louis de Mestier, Anne Couvelard, Anela Blažević, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 10, pp. R391-R405
Open Access | Times Cited: 20
Association between MGMT status and response to alkylating agents in patients with neuroendocrine neoplasms: a systematic review and meta-analysis
Zhirong Qi, Huangying Tan
Bioscience Reports (2020) Vol. 40, Iss. 3
Open Access | Times Cited: 19
Zhirong Qi, Huangying Tan
Bioscience Reports (2020) Vol. 40, Iss. 3
Open Access | Times Cited: 19
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Masatoshi Murakami, Nao Fujimori, Yu Takamatsu, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 6, pp. 647-657
Closed Access | Times Cited: 2
Masatoshi Murakami, Nao Fujimori, Yu Takamatsu, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 6, pp. 647-657
Closed Access | Times Cited: 2
Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives
Susumu Hijioka, Chigusa Morizane, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology (2021) Vol. 51, Iss. 8, pp. 1185-1196
Open Access | Times Cited: 13
Susumu Hijioka, Chigusa Morizane, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology (2021) Vol. 51, Iss. 8, pp. 1185-1196
Open Access | Times Cited: 13
MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimens
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms
Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7557-7557
Open Access | Times Cited: 3
Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7557-7557
Open Access | Times Cited: 3
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 7
The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms
HE Li-ping, Steeve Boulant, Megan L. Stanifer, et al.
Cancer Science (2022) Vol. 113, Iss. 5, pp. 1575-1586
Open Access | Times Cited: 3
HE Li-ping, Steeve Boulant, Megan L. Stanifer, et al.
Cancer Science (2022) Vol. 113, Iss. 5, pp. 1575-1586
Open Access | Times Cited: 3
Systemic Therapy for Pancreatic Neuroendocrine Tumors
Viraj Lavingia, Shruti Gohel, Bhawna Sirohi
Indian Journal of Surgical Oncology (2024) Vol. 15, Iss. S2, pp. 305-314
Closed Access
Viraj Lavingia, Shruti Gohel, Bhawna Sirohi
Indian Journal of Surgical Oncology (2024) Vol. 15, Iss. S2, pp. 305-314
Closed Access
Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
Non-nucleoside O6-methylguanine-DNA methyltransferase inhibitors in murine spontaneous tumor experimental chemotherapy in vivo
L. L. Маcewicz, K. S. Zhuvaka, A. Ye. Papuga, et al.
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 3, pp. 561-566
Open Access
L. L. Маcewicz, K. S. Zhuvaka, A. Ye. Papuga, et al.
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 3, pp. 561-566
Open Access
Inactivation of MGMT is Associated With the Efficacy of Streptozocin and High-grade Pancreatic Neuroendocrine Neoplasms
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Research Square (Research Square) (2023)
Open Access
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Research Square (Research Square) (2023)
Open Access
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
O 6-Methylguanine DNA Methyltransferase and Glucose Transporter 2 in Foregut and Hindgut Gastrointestinal Neuroendocrine Neoplasms
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
Hirofumi Watanabe, Yuto Yamazaki, Fumiyoshi Fujishima, et al.
Research Square (Research Square) (2020)
Open Access
Inactivation of MGMT is Associated With the Efficacy of Streptozocin and High-grade Pancreatic Neuroendocrine Neoplasms
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Research Square (Research Square) (2022)
Open Access
Kohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Research Square (Research Square) (2022)
Open Access
